Last edition
News about "Genentech"
Genentech Invests USD 700M to Build First East Coast Manufacturing Facility in North Carolina
The project represents an initial investment of more than USD 700 million and is part of Roche’s broader USD 50 billion commitment to strengthen US manufacturing infrastructure and R&D. Once completed, the site will create over 1,900 jobs.
Genentech | 28/08/2025 | By Darshana
Genentech Receives Approval from FDA for Alecensa
Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer.
Genentech | 22/04/2024 | By Aishwarya | 447
Genentech, a member of the Roche Group, announced the US Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standard
Genentech | 26/03/2020 | By Darshana | 498
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy